US Stock MarketDetailed Quotes

Drugs Made In America Acquisition Corp (DMAA)

Watchlist
  • 10.600
  • 0.0000.00%
Close May 8 16:00 ET
  • 10.600
  • 0.0000.00%
Post 20:01 ET
357.40MMarket Cap60.23P/E (TTM)

Drugs Made In America Acquisition Corp (DMAA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(Q3)Sep 30, 2024
Total revenue
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
2.82M
2.09M
81.95%263.7K
131.92K
330.93K
144.93K
Selling and administrative expenses
--2.82M
--2.09M
81.95%263.7K
--131.92K
--330.93K
--144.93K
-General and administrative expense
--2.82M
--2.09M
81.95%263.7K
--131.92K
--330.93K
--144.93K
Operating profit
-2.82M
-2.09M
-81.95%-263.7K
-131.92K
-330.93K
-144.93K
Net non-operating interest income expense
8.76M
2.3M
2.45M
2.42M
1.59M
0
Non-operating interest income
--8.76M
--2.3M
--2.45M
--2.42M
--1.59M
--0
Other net income (expense)
Income before tax
5.94M
212.96K
1,607.34%2.18M
2.29M
1.25M
-144.93K
Income tax
Net income
5.94M
212.96K
1,607.34%2.18M
2.29M
1.25M
-144.93K
Net income continuous Operations
--5.94M
--212.96K
1,607.34%2.18M
--2.29M
--1.25M
---144.93K
Minority interest income
Net income attributable to the parent company
5.94M
212.96K
1,607.34%2.18M
2.29M
1.25M
-144.93K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
5.94M
212.96K
1,607.34%2.18M
2.29M
1.25M
-144.93K
Basic earnings per share
0.19
0
1,542.11%0.07
0.07
0.05
-0.0049
Diluted earnings per share
0.19
0
1,542.11%0.07
0.07
0.0492
-0.0049
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(Q3)Sep 30, 2024
Total revenue 000000
Operating revenue --0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 2.82M2.09M81.95%263.7K131.92K330.93K144.93K
Selling and administrative expenses --2.82M--2.09M81.95%263.7K--131.92K--330.93K--144.93K
-General and administrative expense --2.82M--2.09M81.95%263.7K--131.92K--330.93K--144.93K
Operating profit -2.82M-2.09M-81.95%-263.7K-131.92K-330.93K-144.93K
Net non-operating interest income expense 8.76M2.3M2.45M2.42M1.59M0
Non-operating interest income --8.76M--2.3M--2.45M--2.42M--1.59M--0
Other net income (expense)
Income before tax 5.94M212.96K1,607.34%2.18M2.29M1.25M-144.93K
Income tax
Net income 5.94M212.96K1,607.34%2.18M2.29M1.25M-144.93K
Net income continuous Operations --5.94M--212.96K1,607.34%2.18M--2.29M--1.25M---144.93K
Minority interest income
Net income attributable to the parent company 5.94M212.96K1,607.34%2.18M2.29M1.25M-144.93K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 5.94M212.96K1,607.34%2.18M2.29M1.25M-144.93K
Basic earnings per share 0.1901,542.11%0.070.070.05-0.0049
Diluted earnings per share 0.1901,542.11%0.070.070.0492-0.0049
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes----------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More